Fig. 2.
Fig. 2. Survival of lethally irradiated C57BL/Ka mice receiving an intravenous injection of blood mononuclear cells from G-CSF–treated or untreated syngeneic donors. Irradiation and cell injections were performed on day 0. Hosts received either no cells; 2.5 × 106 or 1.25 × 106 Ficoll-purified cells from untreated donors (NORM-Ficoll-PBL); or 2.5, 1.25, or 0.5 × 106 Ficoll-purified cells from G-CSF–treated donors (MOB-Ficoll-PBC). There were 10 mice in each group of hosts. Two experiments were combined.

Survival of lethally irradiated C57BL/Ka mice receiving an intravenous injection of blood mononuclear cells from G-CSF–treated or untreated syngeneic donors. Irradiation and cell injections were performed on day 0. Hosts received either no cells; 2.5 × 106 or 1.25 × 106 Ficoll-purified cells from untreated donors (NORM-Ficoll-PBL); or 2.5, 1.25, or 0.5 × 106 Ficoll-purified cells from G-CSF–treated donors (MOB-Ficoll-PBC). There were 10 mice in each group of hosts. Two experiments were combined.

Close Modal

or Create an Account

Close Modal
Close Modal